Xenia Bovermann
Overview
Explore the profile of Xenia Bovermann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gorlanova O, Ruttimann C, Soti A, de Hoogh K, Vienneau D, Kunstle N, et al.
Chemosphere
. 2024 Jul;
363:142837.
PMID: 39009092
Background: Current knowledge suggests that the gene region containing MUC5B and TOLLIP plays a role in airway defence and airway inflammation, and hence respiratory disease. It is also known that...
2.
Oestreich M, Keller F, Bovermann X, Braun D, Schiller R, Raio L, et al.
Klin Padiatr
. 2024 Jan;
236(2):145-147.
PMID: 38224688
No abstract available.
3.
Habener A, Grychtol R, Gaedcke S, DeLuca D, Dittrich A, Happle C, et al.
Eur Respir J
. 2022 May;
60(5).
PMID: 35595320
Background: Comprehensive studies investigated the role of T-cells in asthma which led to personalised treatment options targeting severe eosinophilic asthma. However, little is known about the contribution of B-cells to...
4.
Maison N, Omony J, Illi S, Thiele D, Skevaki C, Dittrich A, et al.
Eur Respir J
. 2022 Feb;
60(3).
PMID: 35210326
Rationale: In adults, personalised asthma treatment targets patients with type 2 (T2)-high and eosinophilic asthma phenotypes. It is unclear whether such classification is achievable in children. Objectives: To define T2-high...
5.
Bovermann X, Ricklefs I, Vogelberg C, Klimek L, Kopp M
Int Arch Allergy Immunol
. 2021 Jan;
182(6):524-534.
PMID: 33503610
A high-dose, accelerated escalation schedule during subcutaneous allergen-specific immunotherapy (AIT) is safe and well-tolerated in adults. However, there are no data in children and adolescents. The aim of the present...
6.
Stahl M, Joachim C, Kirsch I, Uselmann T, Yu Y, Alfeis N, et al.
ERJ Open Res
. 2020 Dec;
6(4).
PMID: 33263048
Background: Multiple-breath washout (MBW)-derived lung clearance index (LCI) detects early cystic fibrosis (CF) lung disease. LCI was used as an end-point in single- and multicentre settings at highly experienced MBW...
7.
Kopp M, Bovermann X, Klimek L
Int Arch Allergy Immunol
. 2019 Dec;
181(2):94-102.
PMID: 31865326
Only few data on safety during high-dose, accelerated escalation schedules during subcutaneous allergen immunotherapy (AIT) are available. The aim of this study was to assess the safety and tolerability of...